Gut-directed hypnotherapy for irritable bowel syndrome: Piloting a primary care-based randomised controlled trial

British Journal of General Practice

Volumn 56, Issue 523, 2006, Pages 115-121

  Roberts, Lesley ^a   Wilson, Sue ^a   Singh, Sukhdev ^a   Roalfe, Andrea ^a   Greenfield, Sheila ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Hypnotherapy; Irritable bowel syndrome; Randomised controlled trial

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DRUG USE; FEMALE; HUMAN; HYPNOSIS; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; FAMILY PRACTICE; FEMALE; HUMANS; HYPNOSIS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 32344446582     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wilson S, Roberts L, Roalfe A, et al. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 2004; 54: 495-502.
2. Agreus L, Svardsudd K, Nyren O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995; 109(3): 671-680.
3. Thompson WG, Heaton KW. Functional bowel disorders in apparently healthy people. Gastroenterology 1980; 79(2): 283-288.
4. Kennedy TM, Jones RH, Hungin AP, et al. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyperresponsiveness in the general population. Gut 1998; 43(6): 770-774.
5. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38(9): 1569-1580.
6. Talley NJ, Gabriel SE, Harmsen WS, et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109(6): 1736-1741.
7. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003; 17(5): 643-650.
8. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 304: 87-90.
9. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000; 46(1): 78-82.
10. Drossman D, Corazziari E, Talley N, Thompson W, Whitehead W. Rome II: The functional gastrointestinal disorders: diagnosis, pathophysiology and treatment: a multinational consensus. McLean: Degnon Associates, 2000.
11. Harvey RF, Salih SY, Read AE. Organic and functional disorders in 2000 gastroenterology outpatients. Lancet 1983; 1: 632-634.
12. Ferguson A, Sircus W, Eastwood MA. Frequency of 'functional' gastrointestinal disorders. Lancet 1977; 2: 613-614.
13. Fielding JF. A year in out-patients with the irritable bowel syndrome. Ir J Med Sci 1977; 146(6): 162-166.
14. O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci 1995; 50(4): M184-M189.
15. Whitehead WE, Burnett CK, Cook EW III, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996; 41(11): 2248-2253.
16. Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991; 100(4): 998-1005.
17. Francis CY, Whorwell PJ. Bran and irritable bowel syndrome: time for reappraisal. [see comment]. Lancet 1994; 344: 39-40.
18. Poynard T, Naveau S, Mory B, Chaput JC. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8(5): 499-510.
19. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut 2003; 52(11): 1623-1629.
20. Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am J Gastroenterol 2002; 97(4): 954-961.
21. Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome - the effect of hypnotherapy. Aliment Pharmacol Ther 1996; 10(1): 91-95.
22. Whorwell PJ, Prior A, Colgan SM. Hypnotherapy in severe irritable bowel syndrome: further experience. Gut 1987; 28(4): 423-425.
23. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome. Lancet 1984; 2: 1232-1234.
24. Harvey RF, Hinton RA, Gunary RM, Barry RE. Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet 1989; 1: 424-425.
25. Patrick DL, Drossman DA, Frederick IO, et al. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998; 43(2): 400-411.
26. Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000; 95(4): 999-1007.